The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma
The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma have?
The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma has 15 citations in the OpenAlex counts ScholarIQ stores.
When was The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma published?
The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma has 2018 year in the ScholarIQ index.
What is the open-access status of The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma?
The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma has closed oa status in the ScholarIQ index.
What is the DOI of The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma?
The DOI for The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma is on the source record.
What is the PMID of The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma?
The PMID for The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma is on the source record.
What is the OpenAlex record for The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma?
The OpenAlex for The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma is on the source record.